1646. Combined Resistance Analyses From Phase 2b Studies of Presatovir Treatment in RSV-Infected Adults

BACKGROUND: Presatovir is an oral respiratory syncytial virus (RSV) fusion inhibitor in development for the treatment of RSV infection. Results from a healthy volunteer challenge study show that presatovir significantly reduced RSV viral load and clinical signs and symptoms. Here we present combined...

Descripción completa

Detalles Bibliográficos
Autores principales: Porter, Danielle, Guo, Ying, Perry, Jason, Gossage, David, Watkins, Timothy, Chien, Jason, Jordan, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252614/
http://dx.doi.org/10.1093/ofid/ofy209.116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252614/
http://dx.doi.org/10.1093/ofid/ofy209.116

Ejemplares similares